Puxitatug samrotecan
Puxitatug samrotecan (AZD8205) is an antibody-drug conjugate (ADC) targeting B7-H4. Puxitatug samrotecan is composed of the Puxitatug (HY-P990059) antibody targeting B7-H4, randomly conjugated to the Puxitatug samrotecan drug-linker (HY-163487) by reducing inter-chain cysteines. Puxitatug samrotecan has anti-tumor activity and can be used in the study of cancers expressing B7-H4[1].
Product Specifications
CAS Number
[2760250-80-2]
Product Name Alternative
AZD 8205
UNSPSC
12352203
Target
Antibody-Drug Conjugates (ADCs)
Related Pathways
Antibody-drug Conjugate/ADC Related
Applications
Cancer-programmed cell death
Field of Research
Cancer
Purity
98.01
Smiles
[Puxitatugsamrotecan]
References & Citations
Shipping Conditions
Dry Ice
Storage Conditions
-80°C, protect from light
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-171689/Puxitatug-samrotecan-SDS-MedChemExpress.pdf
Scientific Category
ADC Related
Clinical Information
Phase 2
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Recombinant Prochlorococcus marinus subsp. pastoris GTPase obg (obg)
Recombinant Prochlorococcus marinus subsp. pastoris GTPase obg (obg)
Recombinant Prochlorococcus marinus subsp. pastoris GTPase obg (obg)
Recombinant Prochlorococcus marinus subsp. pastoris GTPase obg (obg)
Recombinant Prochlorococcus marinus subsp. pastoris GTPase obg (obg)